000 04019nam a22004215c 4500
999 _c7776
_d7776
001 7776
003 ES-MaUEC
005 20201203160838.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 190513s2019 gw a o |||| 0|eng d
020 _a9783030114466
024 7 _a10.1007/978-3-030-11446-6
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC862
_b.B56 2019 EB
245 0 0 _aBiomarkers in Inflammatory Bowel Diseases
_cedited by Nik Sheng Ding, Peter De Cruz.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2019.
300 _aXVII, 365 páginas 35 ilustraciones, 30 ilustraciones a color
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 0 _aMedicine (Springer-11650)
505 0 _aPart I: Introduction -- nflammatory bowel disease – more than meets the eye - Clinical risk factors – lessons from epidemiology -- Clinical trial design for biomarker discovery -- Database/ big data meets real world -- Patient reported outcomes -- Part II: Biomarkers – Prognostic vs Predictive -- Biomarkers for remote monitoring -- Disease modification -- Part IIV: Crohn’s disease -- Luminal Crohn’s disease-. Perianal CD -- Fibrosis/ strictures in CD -- Post-op Crohn’s disease -- Part IV: Ulcerative colitis -- UC surveillance -- Acute severe UC -- Chronic active UC -- Pouchitis -- Refractory proctitis -- Feacal microbiota transplantation -- Primary sclerosing cholangitis -- Extraintestinal manifestations of IBD -- Part V: Specialised scenarios -- Pregnancy -- Nutrition -- TDM -- Biomarkers to quantify immune response -- Drug toxicity -- Part VI:Scientific -- Exposome and diet -- Microbiota -- Metabonomics -- Immunology -- Genomics -- Systems Biology in Biomarker research -- Part VII: Ideal tools for investigation in the future.
520 3 _aThis book provides a comprehensive and complete overview of biomarkers in clinical practice for inflammatory bowel disease (IBD) bringing together the literature in a clear and concise manner. The book bridges the gap between growing knowledge at the bench and current and future applications of biomarkers in clinical practice. The central structure of the book focuses on prognostic and predictive biomarkers in IBD with an emphasis on the fields of research and scientific techniques (genomics, proteomics and metabonomics) that have led to biomarker discovery and places these biomarkers within a clinical context to help understand their utility in clinical practice. This book will be of use to clinicians who have an interest in using biomarkers in clinical practice as well as clinician researchers and scientists involved in the biomarker research pipeline. The author team comprises experts from around the world in order to bring together the literature in an effort to inform clinicians and researchers about the current state-of-the art in biomarker discovery. It is intended to assist future research efforts and indicate how biomarkers might be best applied to clinical practice both at present and in the future.
988 _aPrimersemestre_2019_Medicine
650 7 _2embne
_9160162
_aEnfermedad inflamatoria intestinal
_xAspectos moleculares
653 0 _aGastroenterology.
653 0 _aMicrobial genetics.
700 1 _aSheng Ding, Nik.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aDe Cruz, Peter.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_982518
710 2 _aSpringerLink (Online service)
_9106937
776 0 8 _iPrinted edition:
_z9783030114459
776 0 8 _iPrinted edition:
_z9783030114473
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-11446-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0
_zSI